🔎 Trials Near Me

Gara Jalqabaatti › Sukkaraa Gosa 2 › Indiana › Indianapolis

Qorannoo klinikaalii Sukkaraa Gosa 2 Indianapolis, IN keessatti

Qorannoo 12 Sukkaraa Gosa 2 f Indianapolis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Namoota walitti qabaa jiraSadarkaa 2
  • Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Namoota walitti qabaa jiraSadarkaa 3
  • American Health Network - Avon, Avon · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07064473

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • Indiana Medical Research Institute, Indianapolis
  • Franciscan Physician Network- Indiana Heart Physicians, Indianapolis
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06112418

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • DM Clinical Research - Indianapolis, Indianapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-2 Clinical Site, Indianapolis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Namoota walitti qabaa jiraSadarkaa 2
  • Investigators Research Group, Brownsburg · Miili 14 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 2
  • Midwest Inst For Clin Res, Indianapolis
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07668388

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Riley Hospital For Children, Indianapolis
Umuriin 10 hanga 18 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07282613

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Namoota walitti qabaa jiraSadarkaa 3
  • American Health Network of IN LLC_Franklin, Franklin · Miili 21 fagaatti
Umuriin 45 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07797335

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Namoota walitti qabaa jiraSadarkaa 3
  • Center for Diabetes and Metabolic Diseases Indiana University, Indianapolis
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06739122

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Namoota walitti qabaa jira
  • Indiana University, Indianapolis
Umuriin 14 hanga 75 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT07579702

Drug Interaction Potential of Pro-Inflammatory Conditions

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Indiana University Hospital, Indianapolis
Umuriin 12 hanga 99 · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT07360938

Qorannoo Sukkaraa Gosa 2 magaalota biroo keessatti

Qorannoo biroo Indianapolis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.